483
Solaris Pharma CorpSolaris Pharma Corp – FDA 483, Apr 21, 2026
Record Details
Scinopharm Pharma Corporation in Somerset, NJ, was cited for significant deficiencies in its quality control capabilities for commercial drug manufacturing. The inspection revealed that the QC laboratory is still under construction and non-functional, essential analytical instruments are missing and unqualified, and analytical methods and procedures are not yet validated or approved by quality assurance. These issues indicate a lack of readiness for commercial production.
- Person
View Company Profile
ID · 1fdd1dbe-84f4-44e9-9138-c3b74a20f81c
Other documents for Solaris Pharma Corp
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.